Trial intelligence / Profile preview

Malarone Pharmacokinetics Under Simulated Physiologic Stressors

NCT03991208Phase 4Withdrawn

Sponsor
Walter Reed Army Institute of Research
Start
May 2019
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atovaquone + proguanil in malaria, sponsored by Walter Reed Army Institute of Research. Planned start May 2019; status: withdrawn.

02

Drugs

atovaquone + proguanil
03

Conditions

malaria

Beyond the preview

Go deeper on NCT03991208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03991208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call